Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities.

about

Sterile Inflammation of Brain, due to Activation of Innate Immunity, as a Culprit in Psychiatric Disorders.Oral Probiotics Ameliorate the Behavioral Deficits Induced by Chronic Mild Stress in Mice via the Gut Microbiota-Inflammation Axis

P2860

Q55069783-17912901-AAF5-4965-A2BD-FEA4D8216493 Q59128134-EEF14FDF-6E58-435D-9420-2B0C4C07677E

P2860

Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities.

Item

http://www.wikidata.org/entity/Q47745353

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities.

@en

Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities.

@nl

type

Item

label

Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities.

@en

Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities.

@nl

prefLabel

Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities.

@en

Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities.

@nl

P1476

Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities.

@en

P2093

Madeline L Pfau

http://www.w3.org/2001/XMLSchema#string

Scott J Russo

http://www.w3.org/2001/XMLSchema#string

P2860

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans

The molecular neurobiology of depression

Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders

Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue

Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence

A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome

Neuron-Microglia Interactions in Mental Health Disorders: "For Better, and For Worse"

Neuroimmune mechanisms of depression

Immune and Neuroendocrine Mechanisms of Stress Vulnerability and Resilience

P304

411-428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1146/ANNUREV-PHARMTOX-010617-052823

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Caroline Ménard

P577

2017-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28992428

http://www.w3.org/2001/XMLSchema#string

P932

5826556

http://www.w3.org/2001/XMLSchema#string

Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities.

about

P2860

P2860

Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932